Literature DB >> 3086977

Cytotoxicity of human pI 7 interleukin-1 for pancreatic islets of Langerhans.

K Bendtzen, T Mandrup-Poulsen, J Nerup, J H Nielsen, C A Dinarello, M Svenson.   

Abstract

Activated mononuclear cells appear to be important effector cells in autoimmune beta cell destruction leading to insulin-dependent (type 1) diabetes mellitus. Conditioned medium from activated mononuclear cells (from human blood) is cytotoxic to isolated rat and human islets of Langerhans. This cytotoxic activity was eliminated from crude cytokine preparations by adsorption with immobilized, purified antibody to interleukin-1 (IL-1). The islet-inhibitory activity and the IL-1 activity (determined by its comitogenic effect on thymocytes) were recovered by acid wash. Purified natural IL-1 and recombinant IL-1 derived from the predominant pI 7 form of human IL-1, consistently inhibited the insulin response. The pI 6 and pI 5 forms of natural IL-1 were ineffective. Natural and recombinant IL-1 exhibited similar dose responses in their islet-inhibitory effect and their thymocyte-stimulatory activity. Concentrations of IL-1 that inhibited islet activity were in the picomolar range. Hence, monocyte-derived pI 7 IL-1 may contribute to islet cell damage and therefore to the development of insulin-dependent diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3086977     DOI: 10.1126/science.3086977

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  135 in total

Review 1.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

Review 2.  Blocking interleukin-1β in acute and chronic autoinflammatory diseases.

Authors:  C A Dinarello
Journal:  J Intern Med       Date:  2011-01       Impact factor: 8.989

Review 3.  Target organ defects in thyroid autoimmune disease.

Authors:  R S Sundick
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

4.  Extracellular factors and immunosuppressive drugs influencing insulin secretion of murine islets.

Authors:  V J Auer; E Janas; V Ninichuk; E Eppler; T S Weiss; S Kirchner; A M Otto; M J Stangl
Journal:  Clin Exp Immunol       Date:  2012-11       Impact factor: 4.330

5.  Glucose-induced beta cell production of IL-1beta contributes to glucotoxicity in human pancreatic islets.

Authors:  Kathrin Maedler; Pavel Sergeev; Frédéric Ris; José Oberholzer; Helen I Joller-Jemelka; Giatgen A Spinas; Nurit Kaiser; Philippe A Halban; Marc Y Donath
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

6.  Existence of both IL-1 alpha and beta in normal human amniotic fluid: unique high molecular weight form of IL-1 beta.

Authors:  T Tamatani; H Tsunoda; H Iwasaki; M Kaneko; T Hashimoto; K Onozaki
Journal:  Immunology       Date:  1988-11       Impact factor: 7.397

7.  IL-1 mediates amyloid-associated islet dysfunction and inflammation in human islet amyloid polypeptide transgenic mice.

Authors:  Clara Y Westwell-Roper; Cyrus A Chehroudi; Heather C Denroche; Jaques A Courtade; Jan A Ehses; C Bruce Verchere
Journal:  Diabetologia       Date:  2014-12-10       Impact factor: 10.122

8.  Islet inflammation and hyperplasia induced by the pancreatic islet-specific overexpression of interleukin-6 in transgenic mice.

Authors:  I L Campbell; M V Hobbs; J Dockter; M B Oldstone; J Allison
Journal:  Am J Pathol       Date:  1994-07       Impact factor: 4.307

Review 9.  Islet microencapsulation: a review.

Authors:  H A Clayton; R F James; N J London
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

10.  Expression of an insulin/interleukin-1 receptor antagonist hybrid gene in insulin-producing cell lines (HIT-T15 and NIT-1) confers resistance against interleukin-1-induced nitric oxide production.

Authors:  N Welsh; K Bendtzen; M Welsh
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.